Skip to main content
. 2024 Nov 29;25(12):427. doi: 10.31083/j.rcm2512427

Fig. 1.

Fig. 1.

Design and enrollment criteria for the multicenter vericiguat treatment study. This flowchart outlines the recruitment process in the context of inclusion and exclusion criteria. NT-proBNP, N-terminal pro-B type natriuretic peptide.